SecBot SecBot
PRESS-RELEASE ·Filed Mar 16, 2026

WW

WW International Inc.
MIXED
Impact 6/10
Horizonweeks Processed8mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ◆ Mixed

Monitor whether WW can stabilize its Behavioral subscriber base while scaling its higher-ARPU Clinical segment. The stock may react to early 2026 subscriber trends and marketing efficiency, especially given the planned reduction in post-Q1 marketing spend.

DirectionMixed
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$21.20
T+0 close · Mar 16, 2026 · via day close
Latest settled
−18.92%
T+60 · $17.19
Vs SPY
−29.40%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 16 $21.20entry
  2. T+1 · 8mo ago −12.17%α −12.44% · $18.62
  3. T+5 · 8mo ago −15.28%α −13.24% · $17.96
  4. T+20 · 7mo ago −49.76%α −53.54% · $10.65
  5. T+60 · 5mo ago −18.92%α −29.40% · $17.19
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

WW International reported Q4 2025 results with total revenue of $162.8 million, down 12% year-over-year, driven by secular declines in its Behavioral business. However, Clinical Subscription Revenue surged 32% YoY to $27 million, with Clinical subscribers up 42% to 130 thousand. The company exceeded 2025 Adjusted EBITDA guidance and provided 2026 revenue guidance of $620–635 million and Adjusted EBITDA of $105–115 million, signaling a strategic shift toward integrated GLP-1 and behavioral health solutions.

Key Financial Metrics

Revenue
$162.8M
-11.7% YoY
EPS
$-0.58
Guidance
$620M-$635M
lowered

Key Facts

  • Q4 2025 Total Revenue: $162.8 million, down 12% YoY
  • Q4 Clinical Subscription Revenue: $27 million, up 32% YoY
  • End of Period Clinical Subscribers: 130 thousand, up 42% YoY
  • Q4 Net Loss: $5.8 million (3.6% margin), Adjusted EBITDA: $18.0 million (11.1% margin)
  • 2026 Full Year Guidance: Revenue $620–635 million, Adjusted EBITDA $105–115 million
  • Company emerged from Chapter 11 in June 2025 and applied fresh start accounting

Financial Impact

Revenue decline of 12% YoY in Q4, but Clinical segment growing rapidly; 2026 revenue guidance implies ~12-15% decline from 2025's $710.6 million

revenueepsebitdasubscriber_countarpu

Risk Factors

  • Continued erosion of Behavioral business may offset Clinical growth
  • Heavy reliance on future Clinical subscriber growth and ARPU expansion
  • Execution risk in transitioning to integrated weight health model
  • Guidance implies continued revenue contraction in 2026

Market Snapshot

Exchange
Nasdaq

Investment Themes

Services

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3256124

Track record

20 reports on WW

Performance horizon

3 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +9.16% at T+20 after the Apr 3, 2026 report. 4 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $9.46 Now $9.46 +0.00% settles Dec 16
  2. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $10.84 Now $9.46 −12.73% settles Dec 15
  3. Nov 10, 20266d ago Insider Cluster Bullish 4/10 Entry $13.05 Now $9.46 −27.51% settles Dec 10
  4. Nov 5, 202611d ago 8-K Mixed 6/10 Entry $12.84 Now $9.46 −26.32% settles Dec 4
  5. Oct 13, 20264w ago SC 13G/A Bearish 4/10 Entry $14.27 to $13.05 Now $9.46 +33.71% ▲ +8.55% +7.28% vs SPY
  6. Sep 9, 20269w ago 8-K Neutral 4/10 Entry $14.94 to $15.08 Now $9.46 −36.68% ▲ +0.94% −1.01% vs SPY
  7. Aug 20, 202612w ago Insider Buy Bullish 5/10 Entry $15.71 to $16.39 Now $9.46 −39.78% ▲ +4.33% +4.85% vs SPY
  8. Jul 23, 202616w ago Press Release Neutral 1/10 Entry $13.34 to $15.71 Now $9.46 −29.09% ▲ +17.77% +14.14% vs SPY
  9. Jun 16, 202621w ago Press Release Bullish 5/10 Entry $19.05 to $14.87 Now $9.46 −50.34% ▼ −21.94% −23.26% vs SPY
  10. Jun 4, 202623w ago DEFA14A Neutral 5/10 Entry $17.27 to $16.31 Now $9.46 −45.21% ▼ −5.53% −4.16% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 16, 2026